Skip to main content
Erschienen in: Current Geriatrics Reports 4/2018

27.10.2018 | DERMATOLOGY AND WOUND CARE (C SAYED AND D CULTON, SECTION EDITORS)

Treatment of Non-melanoma Skin Cancer in the Elderly

verfasst von: Alexandra Zeitany, Adewole Adamson

Erschienen in: Current Geriatrics Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

We seek to explain how the treatment of non-melanoma skin cancer (NMSC) should differ in certain geriatric patients. Our goal is to provide primary care physicians with a comprehensive methodology for approaching the evaluation and management of these patients.

Recent Findings

Recent retrospective studies have revealed that the rates of aggressive surgical treatment of NMSCs are equivalent in non-age restricted and geriatric populations, including those with limited life expectancy. Geriatric patients have higher rates of post-operative complications without affecting disease specific survival. These studies suggest that we must carefully consider how we counsel and treat elderly patients with NMSC.

Summary

There are many surgical and non-surgical treatment modalities for NMSC that offer varying cure rates. Given the non-lethal nature of many of these tumors, active surveillance is another viable treatment alternative especially in patients with limited life expectancy. Ultimately, we must engage in shared decision-making with our patients to develop treatment plans that best align with each patient’s overall goals of care.
Literatur
1.
Zurück zum Zitat • Garvcovich S, et al. Skin cancer epidemics in the elderly as a n emerging issue in geriatric oncology. Aging Dis. 2017;8(5):643–61 This review article highlights the increasing epidemic of NMSC in the elderly in terms of incidence and financial burden.CrossRef • Garvcovich S, et al. Skin cancer epidemics in the elderly as a n emerging issue in geriatric oncology. Aging Dis. 2017;8(5):643–61 This review article highlights the increasing epidemic of NMSC in the elderly in terms of incidence and financial burden.CrossRef
2.
Zurück zum Zitat Leiter U, Keim U, Eigentler T, et al. Incidence mortality, and trends of nonmelanoma skin cancer in Germany. J Investig Dermatol. 2017;137(9):1860–76.CrossRef Leiter U, Keim U, Eigentler T, et al. Incidence mortality, and trends of nonmelanoma skin cancer in Germany. J Investig Dermatol. 2017;137(9):1860–76.CrossRef
3.
Zurück zum Zitat Werner RN, et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169(3):502–16.CrossRef Werner RN, et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169(3):502–16.CrossRef
4.
Zurück zum Zitat NCCN Guidelines: Basal cell carcinoma. 2016. NCCN Guidelines: Basal cell carcinoma. 2016.
5.
Zurück zum Zitat NCCN Guidelines: Squamous cell carcinoma. 2016. NCCN Guidelines: Squamous cell carcinoma. 2016.
6.
Zurück zum Zitat Purnell JC et. al. Conventional versus giant basal cell carcinoma, a review of 57 cases: Histologic differences contributing to excessive growth. Indian J Dermatol 2018: 63(2): 147–154. Purnell JC et. al. Conventional versus giant basal cell carcinoma, a review of 57 cases: Histologic differences contributing to excessive growth. Indian J Dermatol 2018: 63(2): 147–154.
7.
Zurück zum Zitat Rieger KE, et al. Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer. J Cutan Pathol. 2010;37:59–67.CrossRef Rieger KE, et al. Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer. J Cutan Pathol. 2010;37:59–67.CrossRef
8.
Zurück zum Zitat Swetter SM et. al. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. J Cutan Pathol 2003: 30: 139–146.CrossRef Swetter SM et. al. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. J Cutan Pathol 2003: 30: 139–146.CrossRef
9.
Zurück zum Zitat • Bouhassira J et. al. Factors associated with postoperative complications in elderly patients with skin cancer: a retrospective study of 241 patients. J Geriatr Onc 2016: 10–14. Single-center retrospective study that evaluated the post -operative complication rate of patients older than 75 undergoing treatment of their NMSC.CrossRef • Bouhassira J et. al. Factors associated with postoperative complications in elderly patients with skin cancer: a retrospective study of 241 patients. J Geriatr Onc 2016: 10–14. Single-center retrospective study that evaluated the post -operative complication rate of patients older than 75 undergoing treatment of their NMSC.CrossRef
10.
Zurück zum Zitat Linos E, VanBeek M, Resneck JS. A sudden and concerning increase in the use of electronic brachytherapy for skin cancer. JAMA Dermatol. 2015;151(7):699–700.CrossRef Linos E, VanBeek M, Resneck JS. A sudden and concerning increase in the use of electronic brachytherapy for skin cancer. JAMA Dermatol. 2015;151(7):699–700.CrossRef
11.
Zurück zum Zitat • Chauhan R et. al. Age at diagnosis as a relative contraindication for intervention in facial nonmelanoma skin cancer. JAMA Surgery 2018: E1-E2. Single-center retrospective study that revealed that disease specific survival was not affected by excision of small facial NMSC. • Chauhan R et. al. Age at diagnosis as a relative contraindication for intervention in facial nonmelanoma skin cancer. JAMA Surgery 2018: E1-E2. Single-center retrospective study that revealed that disease specific survival was not affected by excision of small facial NMSC.
12.
Zurück zum Zitat Feng H, Belkin D, Geronemus RG. Geographic distribution of U.S. Mohs micrographic surgery workforce. Dermatol Surg. 2018, 1. Feng H, Belkin D, Geronemus RG. Geographic distribution of U.S. Mohs micrographic surgery workforce. Dermatol Surg. 2018, 1.
13.
Zurück zum Zitat Linos E, Berger T, Chren M. Point: care of potential low-risk basal cell carcinoma at the end of life. J Am Acad Dermatol. 2015;73(1):151–61.CrossRef Linos E, Berger T, Chren M. Point: care of potential low-risk basal cell carcinoma at the end of life. J Am Acad Dermatol. 2015;73(1):151–61.CrossRef
14.
Zurück zum Zitat Lee et. al. Comorbidity assessment in skin cancer patients: a pilot study comparing medical interview with a patient-reported questionnaire. J of Skin Cancer 2015: 1–6.CrossRef Lee et. al. Comorbidity assessment in skin cancer patients: a pilot study comparing medical interview with a patient-reported questionnaire. J of Skin Cancer 2015: 1–6.CrossRef
15.
Zurück zum Zitat Rogers EM, Connolly KL, Nehal KS, et al. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer. JAAD. 2018;78(6):1119–24.CrossRef Rogers EM, Connolly KL, Nehal KS, et al. Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer. JAAD. 2018;78(6):1119–24.CrossRef
16.
Zurück zum Zitat Linos E, et al. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med. 2013;173(11):1006–12.CrossRef Linos E, et al. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med. 2013;173(11):1006–12.CrossRef
17.
Zurück zum Zitat • Linos E, Chren MM, Covinsky K. Geriatric dermatology- a framework for caring for older patients with skin disease. JAMA Dermatol. 2018: E1-E2. Editorial on geriatric dermatology that highlights the importance of considering unique patient characteristics when evaluating elderly patients and advocates for explicitly incorporating geriatrics into dermatology in a manner similar to pediatrics in dermatology. • Linos E, Chren MM, Covinsky K. Geriatric dermatology- a framework for caring for older patients with skin disease. JAMA Dermatol. 2018: E1-E2. Editorial on geriatric dermatology that highlights the importance of considering unique patient characteristics when evaluating elderly patients and advocates for explicitly incorporating geriatrics into dermatology in a manner similar to pediatrics in dermatology.
18.
Zurück zum Zitat • Linos E et. al. Skin cancer in US elders: does life expectancy play a role in treatment decisions? J Am Geratr Soc 2016: 64(8): 1610-1615. This retrospective study analyzed the treatment modality used to treat NMSC in over 9500 older than age 65. It revealed that most NMSC were treated surgically. • Linos E et. al. Skin cancer in US elders: does life expectancy play a role in treatment decisions? J Am Geratr Soc 2016: 64(8): 1610-1615. This retrospective study analyzed the treatment modality used to treat NMSC in over 9500 older than age 65. It revealed that most NMSC were treated surgically.
19.
Zurück zum Zitat • Jung J, Linos E. Adding active surveillance as a treatment option for low risk skin cancers in patients with limited life expectancy. J of Geriatr Onc. 2016;7:221–2. Editorial on why the concept of watchful waiting is so difficult for clinicians and postulates that while fear of litigation is partly responsible, the true driving factor is a concern about not giving our patients the “gold standard”.CrossRef • Jung J, Linos E. Adding active surveillance as a treatment option for low risk skin cancers in patients with limited life expectancy. J of Geriatr Onc. 2016;7:221–2. Editorial on why the concept of watchful waiting is so difficult for clinicians and postulates that while fear of litigation is partly responsible, the true driving factor is a concern about not giving our patients the “gold standard”.CrossRef
Metadaten
Titel
Treatment of Non-melanoma Skin Cancer in the Elderly
verfasst von
Alexandra Zeitany
Adewole Adamson
Publikationsdatum
27.10.2018
Verlag
Springer US
Erschienen in
Current Geriatrics Reports / Ausgabe 4/2018
Elektronische ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-018-0264-y

Weitere Artikel der Ausgabe 4/2018

Current Geriatrics Reports 4/2018 Zur Ausgabe

Geriatric Orthopedics (E Meinberg, Section Editor)

Fragility Fractures in the Developing World: a Rising Challenge

Physical Therapy and Rehabilitation (O Addison, Section Editor)

Distinguishing Comorbidity, Disability, and Frailty

Dermatology and Wound Care (C Sayed and D Culton, Section Editors)

The Impact of Sunlight on Skin Aging

Geriatric Orthopedics (E Meinberg, Section Editor)

Current Evaluation and Management of Vertebral Compression Fractures

Dermatology and Wound Care (C Sayed and D Culton, Section Editors)

Autoimmune Blistering Disorders in the Geriatric Population

Infectious Diseases in the Elderly (T Rowe, Section Editor)

Vaccinations for Older Adults

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.